PHOENIX BIOTECH ACQUISITION's ticker is and the CUSIP is 71902K204. A total of 38 filers reported holding PHOENIX BIOTECH ACQUISITION in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,068,000 | +3.6% | 100,000 | 0.0% | 0.27% | +29.0% |
| Q4 2022 | $1,031,000 | +2.2% | 100,000 | 0.0% | 0.21% | +42.9% |
| Q3 2022 | $1,009,000 | +0.1% | 100,000 | 0.0% | 0.15% | -7.0% |
| Q2 2022 | $1,008,000 | +0.2% | 100,000 | 0.0% | 0.16% | +10.5% |
| Q1 2022 | $1,006,000 | -0.3% | 100,000 | 0.0% | 0.14% | +13.5% |
| Q4 2021 | $1,009,000 | – | 100,000 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Yakira Capital Management, Inc. | 100,000 | $1,031,000 | 0.21% |
| FLOW TRADERS U.S. LLC | 10,247 | $104 | 0.01% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| Tower Research Capital LLC (TRC) | 175 | $2 | 0.00% |